Совершенствование методов профилактики и патогенетической терапии бронхолегочной дисплазии у недоношенных детей
Диссертация
Одним из основных факторов риска БЛД принято считать наличие у ребенка тяжелого респираторного дистресс-синдрома (РДС). Методами лечения РДС являются респираторная терапия и заместительная терапия препаратами экзогенного сурфак-танта. Однако, несмотря на широкое применение сурфактантной заместительной терапии и усовершенствование методов респираторной поддержки, БЛД продолжает оставаться одним… Читать ещё >
Список литературы
- Антонов А.Г., Рындин А. Ю. Сурфактант-BL в комплексной терапии респираторных наоушений v новооожденных детей. // Обшая оеаниматология. 2007 — № 3ш/ * ± л.1. С.59−64.
- Балаболкин И. И. Бронхиальная астма у детей. // Москва «Медицина» 2003 — С. 17−27.
- Богдан И.Я. Дыхательная терапия тяжелых форм РДС у глубоконедоношенных детей в раннем неонатальном периоде. // Автореф. дисс. канд. мед. наук. М- 2000 -С. 24.
- Волков И.К. Эмфизема легких у детей. // Эмфизема легких. // Под ред. А. В. Аверьянова (Серия монографий Российского респираторного общества). Атмосфера М — 2009 — С. 92−97.
- Володин H.H. Принципы ведения новорожденных с респираторным дистресс синдромом. // Методические рекомендации. 2008 — С. 2−31.
- Геппе H.A., Розинова H.H., Волков И. К., Мизерницкий Ю. Л. Рабочая классификация основных клинических форм бронхолёгочных заболеваний у детей. // Трудный пациент. 2009 — № 1 — С. 2.
- Геппе H.A., Розинова H.H., Волков И. К. и др. Новая рабочая классификация бронхолёгочных заболеваний у детей. // Доктор.ру 2009 — 1- С.7−13.
- Гланц С. Медико-биологическая статистика. // Пер. с англ. Практика.- М 1999 -С.459.
- Гребенников В.А., Миленин О. Б., Рюмина И. И. Респираторный дистресс-синдром у новорожденных: заместительная терапия синтетическим сурфактантом Экзосурф неонатал.// Вестник мед. М — 1995 — С. 136.
- Ю.Гребенников В. А., Ионов О. И., Мостовой A.B., Овсянников Д. Ю., Дегтярев Д. Н. Дыхательные расстройства. // Неонатология: национальное руководство. // Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа, 2007 — С. 260−280.
- П.Гребенников В. А., Ионов О. И., Мостовой A.B., Овсянников Д. Ю., Дегтярев Д. Н. Дыхательные расстройства. // Неонатология: национальное руководство. Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа, 2007 — С. 273−276.
- Гребенников В.А., Ионов О. И., Мостовой A.B., Овсянников Д. Ю., Дегтярев Д. Н. Дыхательные расстройства. /У Неонатология: национальное руководство. Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа, 2007 — С. 284.
- З.Гребенников В. А., Ионов О. И., Мостовой A.B., Овсянников Д. Ю., Дегтярев Д. Н. Дыхательные расстройства. // Неонатология: национальное руководство. Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа, 2007 — С. 289.
- Гребенников В.А. Интенсивная терапия дыхательных расстройств у новорожденных в критических состояниях. // Диссертация на соискание ученой степени доктора мед. наук. М — 1995 — С. 48.
- Дедов И.И., Петеркова В. А., Сёмичева Т. В., Тюльпаков А. Н. Эндокринопатии. // Неонатология: национальное руководство. Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа, 2007 -С. 601.
- Дементьева, Г. М. Пульмонологические проблемы в неонатологии. //Пульмонология. 2001. — № 1. — С. 6−12.
- Демин В.Ф., Ключников С. О., Самсыгина Г. А. Патология новорожденных и детей раннего возраста. // Лекции по педиатрии. РГМУ -М 2002- № 2 — С. 25.
- Киртбая А.Р. Оптимизация подходов к респираторной терапии новорожденных детей с очень низкой и экстремально низкой массой тела. // Дисс. на соиск. уч. ст. к. м. н.-М- 2009-С. 56−78.
- Кузьмина Т.Б. Прогнозирование бронхолегочных заболеваний в раннем возрасте у детей, находившихся на искусственной вентиляции легких в неонатальном периоде. // Автореф. дис. к. м. н.- М. 1996. — С.24.
- Лесфилд С. Бронхолегочная дисплазия. // Педиатрия по Нельсону. Под ред. Бер-мана Р. Э., Клигмана Р. М., Джонсона X. Б. ООО «Рид Элсивер» — М- Т. 4 — 2009. -С.589−591.
- Лычагина Д.В. Оптимизация профилактики и лечения бронхолегочной дисплазии у недоношенных детей. // Дисс. на соискание уч. ст. к. м. н. M — 2003 — С. 35.
- Макогон A.B., Вараксин H.A., Рябичева Т. Г. Уровни цитокинов при синдроме воспалительного ответа у плода. // Цитокины и воспаление. 2007- Т. 6 — № 4. — С. 4247
- Овсянников Д.Ю., Кузьменко Л. Г., Пушко Л. В., и др. Синдром рецидивирующей бронхиальной обструкции у детей и вклад инфекции в его развитие. // Вестник РУДН, — Сер. «Медицина». Юбилейный выпуск, — 2006.-№ 2.-С.139−144.
- Петрова Н. А., Добродеева И. В., Пальчик А. Б., Шабанов Н. П. Апноэ и периодическое дыхание у новорожденных детей с бронхолегочной дисплазией. // Педиатрия. -2009. -Т. 87 № 1. — С. 13−18
- Петеркова В.А., Семичева Т. В., Кузнецова Э. С., Карева М. А., Яровая И. С. Врожденная дисфункция коры надпочечников у детей. // Пособие для врачей. М.- 2003.
- Реброва О.Ю. Статистический анализ медицинских данных.применение пакета прикладных программ 31аизиса. /7 Медиа Сфера. -2006.- С. 305.
- Розенберг О. А. Легочный сурфактант и его применение при заболевании легких. // Общая реаниматология. 2007 — Т. З — № 1 — С.66−77.
- Розенберг О. А., Баутин А. Е., Осовских В. В. и др. Сурфактант- терапия синдрома острого повреждения легких. // В кн.: 2 Междунар. конгр. по респираторной поддержке. Красноярск. — 2005 — С. 97—98.
- Рындин А. Ю. Бронхолегочная дисплазия. // Рациональная фармакология в акушерстве и гинекологии. Под ред. В. И. Кулаков, Серов В. Н. М.: Литера, — 2005. С. 886−891.
- Рябчикова Н.П., Злыгарева Н. В., Моисеева Е. В. и др. Клиническая характеристика детей с бронхолегочной дисплазией. // Вопросы современной педиатрии. 2006 — Т. 5 — № 1,-С. 506.
- Самсыгина Г. А., Шабалов Н. П., Дегтярева М. В. Сепсис. // Неонатология: национальное руководство. Под ред. Н. Н. Володина. М.: ГЭОТАР-Медиа. — 2007. — С. 681.
- Старевская С. В. Исходы бронхолегочной дисплазии. // Пульмонология. Приложение. XIII Национальный конгресс по болезням органов дыхания. Сб. резюме. 2003 -С. 351.
- Столл Б. Дж., Клигман Р. М. Поражения дыхательных путей. // Педиатрия по Нельсону. Под ред. Берман Р. Э., Клигман Р. М., Джонсон X. Б. ООО «Рид Элсивер"-М- Т. 1.-2009.-С. 371−399.
- Таболин В.А. „Функции надпочечников у плодов, новорожденных и грудных детей“. // Медицина. -М-1975, — С. 263.
- Тюрин И. Е. Методы визуализации хронической обструктивной болезни легких. // Хроническая обструктивная болезнь легких. Под ред. А. 1. Чучалина (Серия монографий Российского респираторного общества). М.: Атмосфера.- 2008. — С. 231−263.
- Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. // Основы доказательной медицины. Пер. с англ. -М.: Медиа Сфера. 1998.- С. 352.
- Харченко М. В. Клинико-функциональные и иммунологические критерии формирования бронхолегочной патологии у детей, находящихся на ИВЛ в неонатальном периоде. // Автореферат дисс. к.м.н. Воронеж.- 2005.- С. 25.
- Цинзерлинг В.А., Мельникова В. Ф. Перинатальные инфекции: вопросы патогенеза, морфологической диагностики и клинико-морфологических сопоставлений. // Практическое руководство. „Элби СпБ“ 2002.-С.352.
- Шабалов Н. П. Детские болезни. // СПб.: Питер. 2008 — Т. 1. — С. 928.
- Шабалов Н. П. Неонатология. // МЕДпресс-информ. -М- 2004- Т.1. С. 163.
- Шабалов Н.П., прилож. IV, „Показания для применения высокочастотной осцил-ляторной вентиляции легких“. // В кн. „Неонатология“. МЕДпресс-информ. М.-2004. — Т.2. — С.615.
- Шишко Г. А., Устинович Ю. А. Современные подходы к ранней диагностике и лечению бронхолегочной дисплазии. // Учебно-методическое пособие для врачей. Мн.:БелМАПО 2006- С. 34.
- Эммануилидис Г. К., Байлен Б. Г. Сердечно-легочный дистресс у новорожденных. //Мед. М. -1994. — С. 387−391.
- Ю В.В. X. Респираторные расстройства у новорожденных. // Медицина. М.- 1989. — С.176.
- Aaltonen R., Heikkinen T, Hakala K, et al. Transfer of proinflamatory cytokines across term placenta. // Obstet Gynecol. 2005- № 106.- P.802−807.
- Abman S. H., Wolfe R. R., Accurso F. J. Pulmonary vascular responce to oxygen in infants with severe bronchopulmonary dysplasia. // Pediatrics/ -1985-№ 75 P. 80−84.
- Adamson I.Y., Young L, King G.M. Reciprocal epithelial: fibroblast interactions in the control of fetal and adult rat lung cells in culture. // Exp Lung Res. 1991 — 17(4).- P.821−35
- Agrons G.A., S.E. Courtney, J.T.Stocker, R.I.Marcowitz. Lung disease in premature neonates: radiologic-pathologic correlation. // Radiographics. 2005.- v.25 — № 4- P. 10 471 073
- Akram Khan M, Kuzma-O'Reilly B, Brodsky N.L., Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. // J. Perinatol. 2006- № 26(7) -P.428−35.
- Alnahhas M.H., Karathanasis P, Kriss V.M., et al. Elevated laminin concentracions in lung secretions of preterm infants supported by mechanical ventilasion are correlated with radiographic abnormalities. // J. Pediatr. 1997 — № 131 — P. 555.
- Alymkulov D.A., Belov G.V., Akhmetova M.I. The correction of hypoxic damage to the pulmonary surfactant system of rats with extremely high-frequency electromagnetic fields. // Vopr Kurortol Fizioter Lech Fiz Kult. 1996 — № 1- P.9−11.
- Aminos G.F. Postnatal Corticosteroids to Treat or Prevent Chronic Lung Disease in Preterm Infants. // Pediatrics. American Academy of pediatrics. 2002 — № 109(2) — P.330 -338.
- An H., Nishimaki S., Ohyama M., et al. Interleukin-6, Inter-eukin-8 and soluble tumor necrosis factor receptor-1 in the cord blood as predictor of chronic lung disease in premature infants. // Am. J. Obsts. Gynecol. 2004 — № 191(5) — P. 1649−1654.
- Awasthi S., Coalson J.J., Yoder B.A., Crouch E., King R.J. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. // Am. J. Respir. Crit. Care Med. 2001 — № 163(2) — P.389−97.
- Baggiolini M., Walz A., and Kunkel S.L. Neutrophilactivating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. // J. Clin. Invest. 1989 — № 84 — P. 1045−1049.
- Bankalari E,. Claure N., Gonzales A. Patent ductus arteriosus and respiratory outcome in premature infants. // Biol Neonate. 2005 — № 88 — P. 192−201.
- Bankalari E., Claure N., Sosenko I.R.S. Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. // Semin. Neonatol. 2003 — № 8 — P. 63−71.
- Bankalari E., Abdenour G.E., Feller R., et al. Bronchopulmonary dysplasia: clinical presentation. // J. Pediatr. 1979 — № 85- P. 819−823.
- Bankalari E., Gerchardt T. Bronchopulmonary dysplasia. // Pediatr. Clin. J. Amer. -1986.-Vol.33, № 1.- P. 1−23.
- Banks B.A., StoufferN., Cnaan A., Ning Y., Merrill J.D., Ballard R.A., Ballard P.L. Association of plasma Cortisol and chronic lung disease in preterm infants. // Pediatrics. -2001 № 107 — P. 494−498.
- Bartraum U., Speer C.P. The role of transforming growth factor P in lung development and disease. // Chest. 2004 — № 125 — P. 754−765.
- Bazzoni F., Cassatella M.A., Rossi F., Ceska M., Dewald B., and Baggiolini M. Phagycytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8. // J. Exp. Med. 1991. — № 173 — P. 771−774.
- Beutler B., Cerami A. Cachectin (tumor necrosis factor): a macrophage hormone governing cellular metabolism and inflammatory response. // Endocr Rev. 1988 — № 9(1) — P. 57−66.
- Bolt R.J., van Weissenbruch M.M., Lafeber H.N. and Delemarre-van-de Waal H.A. Glucocorticoids and lung development in the fetus and preterm infant. // Pediatr. Pulmonol. -2001 -№ 32-P. 76−91.
- Boyce T.G., Mellen B.G., Mitchel E.F., Jr., et al. Rates of hospitalization for respiratory syncytial virus infection among children in medic aid. // J. Pediatr. 2000 — № 137(6) — P. 865−870T.
- Brus F., van Oeveren W., Okken A., et al. Activation of circulating polymorphonuclear leukocytes in preterm infants with severe idiopathic respiratory distress syndrome. // Pediatr. Res. 1996 — № 39 — P. 456.
- Burri P. Lung development and pulmonary angiogenesis. // In: Gaultier CBJ, Post M, eds. Lung development. New York: Oxford University Press. 1999 — P. 543.
- Burris T.P., Guo W., McCabe E.R. The gene responsible for adrenal hypoplasia congenita, DAX-1, encodes a nuclear hormone receptor that defines a new class within the su-perfamily. // Recent. Prog. Horm. Res. 1996 — P. 32.
- Capoluongo E., Vento G., Santonocito C., Matassa P.G., Vaccarella C., Giardina
- Cartom F.A. Case records of the Massachusetts General Hospital. Weekly clinicopatho-logical exercises. Case 40−1999. A four-month-old girl with chronic cyanosis and diffuse pulmonary infiltrates. // N. Engl. J. Med. 1999 — № 341 (27) — P. 2075−2083.
- Cerdan C» Martin Y. Braillv H. Courcoul M. Flavetta S. Costello R. Mawas C. BjrgJF., Olive D. IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways. // J. Immunol. 1991 — № 15,146(2) — P. 560−4.
- Charafeddine L., D’Angio C.T., Phelps D.L. Atypical chronic lung disease patterns in neonates. // Pediatrics. 1999 — № 103 — P. 759−765.
- Choi C.W., Kim B.I., Kim H.S., Park J.D., Choi J.H., Son D.W. Increase of interleukin-6 in tracheal aspirate at birth: a predictor of subsequent bronchopulmonary dysplasia in preterm infants. // Acta Paediatr. 2006 — 95(1) — P. 38−43.
- Chotigeat U., Promwong N., Kanjanapattanakul W., Khorana ML, Sangtawesin V., Horpaopan S. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods. // J. Med. Assoc. Thai. 2008 — № 3 — P. SI09−14.
- Clark P.W., Bloomfield F.H., Harding J.E., Teele R.L. Early chest radiographs in very low birth weight babies receiving corticosteroids for lung disease. // Pediatr. Pulmonol. -2001 -№ 31(4)-P. 297−300.
- Coalson J.J. Pathology of new bronchopulmonary dysplasia. // Semin. Neonatl. 2003 -№ 8-P. 73−81.
- Cohn R.C., Kercsmar C., Dearborn D. Safety and efficacy of flexible endoscopy in chil-ren with bronchopulmonary dysplasia. // Am. J. Dis. Child. 1988 — № 142 — P. 1225−1228.
- Crowley P.A. Antenatal corticosteroid therapy: A meta-analysis of the randomized trials, 1972 to 1994. // Am. J. Obstet. Gynecol. 1995. — № 173 — P. 322−335.
- Dani C., Cecchi A., Bertini G. Role of oxidative stress as physiopathologic factor in the preterm infant. // Minerva. Pediatr. 2004 — № 56, — P. 381−394.
- Downing G.J., Kilbride H.W. Evaluation of airway complications in highrisk preterm infants: application of flexible fiberoptic airway endoscopy. // Pediatrics. 1995 — № 95 -P. 567−572.
- Dulkys Y. et al. Natural porcine surfactant augments airway inflammation after allergen challenge in patients with asthma. // Am. J. Respir.Crit. Care Med. 2004 — № 169 — P. 578—581.
- Eber E., Zach M.S. Long term sequealae of bronchopulmonary dysplasia (chronic lung disease of infancy). // Thorax. 2001. — № 56 — P. 317−323.
- Economou J.S., McBride W.H., Essner R., Rhoades K., Golub S., Holmes
- E.C., Morton D.L. Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo. /7 Immunology. 1989 — № 67(4) — P. 514−9.
- Edwards D.K. Radiographic aspects of bronchopulmonary dysplasia. // J. Pediatr. -1979-№ 95-P. 823.
- Fajardo C., Alvarez J., Wong A. et al. The incidence of obstructive apneas in preterm infants with and without bronchopulmonary dysplasia. // Early Human Development. -1993 -№ 32-P. 197−206.
- Findlay R.D., Taeusch H.W. and Walther F.J. Surfactant replacement therapy for meconium aspiration syndrome. // Pediatrics. — 1996 № 97 — P. 48−52.
- Fitzgerald D.A., Van Asperen P.P., Lam A.H., De Silva M., Henderson-Smart D.J.Chest radiograph abnormalities in very low birthweight survivors of chronic neonatal lung disease. // J. Paediatr. Child Health. 1996 — № 32(6) — P. 491−4.
- Freezer N.J., Sly P.D. Predictive value of measurements of respiratory mechanics in preterm infants with HMD. // Pediatr. Pulmonol. 1993 -№ 16(2) — P. 116−23.
- Fujiwara T., Maeta H., Chida S., Morita T., Watabe Y. and Abe T. Artificial surfactant therapy in hyaline membrane disease. // Lancet. 1980 — № 1 — P. 55−59.
- Gahring L.C., Buckley A., Daynes R.A. Presence of epidermal-derived thymocyte activating factor/interleukin 1 in normal human stratum corneum. // J. Clin. Invest. 1985- № 76(4) P. 1585−91.
- Gatelais F., Berthelot J., Beringue F., Descamps P., Bonneau D., Limal J.M. Coutant
- R. Effect of single and multiple courses of prenatal corticosteroids on 17133hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. // Pediatr. Res. 2004 — № 56(5) — P. 701−5.
- Gaumond B., et al. // Presented at the 88th Annual Meeting of the American Society for Microbiology. 1988.
- Gerdes J. S. Bronchopulmonary dysplasia In Polin R.A. et al. (eds) // Workbook in Practical Neonatology, 2nd ed Philadelphia, W.B. Sannders. 1993. — P. 189−206.
- Gerhardt T., Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. // Biol. Neonate. 1980 — № 38 — P. 96−105.
- Ghezzi F., Maymon E., Edwin S.S., Mazor M., Yoon B.H., Gomez R., Romero R. The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. // Am. J. Obstet. Gynecol. 1999 — № 181(5 Pt 1) — P. 1142−8.
- Ghezzi F., Gomez R., Romero R., Yoon B.H., Edwin S.S., David C., Janisse
- J., Mazor M. Elevated interleukin-8 concentrations in amniotic fluid of mothers whose neonates subsequently develop bronchopulmonary dysplasia. // Eur. J. Obstet. Gynecol. Re-prod. Biol. 1998 — № 78(1) — P. 5−10.
- Girardin E., Grau G.E., Dayer J.M., Roux-Lombard P., Lambert P.H. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. // N. Engl. J. Med. 1988 -№ 18−319(7) — P. 397−400.
- Goldberg R.L., Rouse D.J. Prevention of premature birth. // N. Engl. J. Med. — 1998 -№ 339-P. 313−320.
- Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. // N. Engl. J. Med. 2000 — № 342 — P. 1500−1507.
- Gomez R., Romero R., Ghezzi F., Yoon B.H., Mazor M., Berry S.M. The fetal inflammatory response syndrome. // Am. J. Obstet. Gynecol. 1998 — № 179(1) — P. 194−202.
- Gonzalez A. Sosenko I.R.S., Chandar J., Hummler H., Claure N. and Bankalari E. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams and less. // J. Pediatr. 1996 — № 128 — P. 470−478.
- Gray P.H., Sarkar S., Young J., Rogers Y.M. Conductive hearing loss in preterm infants with bronchopulmonary dysplasia. // J. Paediatr. Child. Health. 2001 — № 37 — P. 278−282.
- Greenough A., Kawadia K., Johnson A. H. et al. A new simple chest radiograph score to predict chronic lung disease in prematurely born infants. // British. J. Radiol. -1999-№ 72-P. 530−533.
- Gregory T.J., Steinberg K.P., Spragg R., et al. Bovine surfactant therapy for patients with acute respiratory distress syndrome. // Am. J. Resp. Crit. Care Med. — 1997 № 155 — P.1309−1315.
- Grob P.M., David E., Warren T.C., De Leon R.P., Farina P.R. and Homon C.A. Characterization of a receptor for human monocyte-derived neutrophil chemotactic fac-tor/interleukin-8. //J.Biol. Chem. 1990 — № 265- P. 8311−8316.
- Groneck P., Goetze-Speer B., Speer C.P. Inflammatory bronchopulmonery response of preterm infantswith microbal colonization of the airways at birth. // Arch. Dis. Child -1996-№ 97-P. 210−215.
- Groneck P., Reuss D., Goetze-Speer B. Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of preterm infants at risk of chronic lung disease. // J. Pediatr. 1993- № 122- P. 938−944.
- Groneck P., Schmale J., Soditt V. et al. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. // Pediatr. Pulmonol. 2001 — № 31-P. 331−338.
- Groneck P., Speer C.P. Inflammatory mediators and bronchopulmonary dysplasia. // Arch. Dis. Child Fetal. Neonatal. Ed. 1995- № 73 — P. Fl.
- Hack M., Horbar J.D., Malloy M.H., Tyson J.E., Wright E. and Wright L. Very Low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Network. // Pediatrics. 1991 — № 87 — P. 587−597.
- Harding J.E., Pang J., Knight D.B., Liggins G.C. Do antenatal corticosteroids help in the setting of preterm rupture of membranes? // Am. J. Obstet. Gynecol. 2001 — № 184 -P. 131−139.
- Heckmann M., Wudy S.A., Haack D., Pohlandt F. Serum Cortisol concentrations in ill preterm infants less than 30 weeks gestation age. // Acta. Pediatr. 2000 — № 89 — P. 10 981 103.
- Heckmann M., Wudy S.A., Haack D., Pohlandt F. Reference range for serum Cortisol in well preterm infants. // Arch. Dis. Child Fetal Neonatal Ed. 1999 — № 81(3) — P. F171−4.
- Hingre R.V., Gross S.J., Hingre K.S., Mayes D.M., Richman R.A. Adrenal steroidogenesis in very low birth weight preterm infants. // J. Clin. Endocrinol. Metab. 1994 -№ 78 — P. 266−270.
- Hjalmarson O., Sandberg K.L. Lung function at term reflects severity of bronchopulmonary dysplasia. // J. Pediatr. 2005 — № 146(1) — P. 3A.
- Huysman M.W.A., hokken-Koelega A.C.S., De Ridder M.A.J., Sauer P.J. Adrenal function in sick very preterm infants. // Pediatr. Res. 2000 — № 48 — P. 629−633.
- Hodjman J.E. Relationship between Wilson-Mikity syndrome and the new bronchopulmonary dysplasia. // Pediatrics. 2003 — № 112 — P. 1414−1415.
- Ilene R.S., Sosenko M.D., Bancalari E. M.D. The newborn lung. // The newborn lung. 2008. — Ch.9. — P. 196.
- James D.K. High Risk Pregnancy: Management Options (Hardcover). // E. Elsevier Inc., Ed. 3 -2006. P. 590−591.
- Jasin H.E., Dingle J.T. Human mononuclear cell factors mediate cartilage matrix degradation through chondrocyte activation. // J. Clin. Invest. 1981 -№ 68(3) — P. 571−81.
- Jeffery P.K. The development of large and small airways. // AM J. Respir. Crit. Care Med. 1998. -№ 157-P. S174-S180.
- Jeffrey A. Whitsett M.D., Timothy E. Weaver PhD. Hereditary Disorders of alveolar Homeostasis in the newborn. // The newborn lung: neonatology questions and controversies. Edited by E.Bancalari. 2008 — Ch.2 — P. 42−49.
- Jeng S. F., Hsu C. H., Tsao P. N. et al. Bronchopulmonary dysplasia predicts adverse developmental and clinical outcomes in very-low-birth infants. // Dev.Med. Child Neurol. -2008. -V. 50. № 1. P. 51−57.
- Jobe A., Kallapur S., Moss T. InflammationUnfection: Effects on fetalnewborn lung. // The newborn lung: neonatology questions and controversies. Edited by E.Bancalari. -2008 Ch.6 — P. 126.
- Jobe A.H. and Bancalari E. Bronchopulmonary dysplasia. NICHD/NHLBI/ORD. Workshop summary. // Am. Resp. Crit. Care. Med 2001. — № 163 — P. 1723−1729.
- Jobe A.H., Newnham J.P., Willet K.E., et al. Endotoxin-induced lung maturation in preterm lambs is nit mediated by Cortisol. // Am. J. Respir. Crit. Care. Med. 2000 — № 162 -P. 1656−1661.
- Jobe A.H., Ikegami M. Mechanisms initiating lung injury in the preterm. // Early Hum Dev. 1998 — № 53(1) — P. 81−94.
- Jobe A.H. The new BPD: an arrest of lung development. // Pediatr. Res. 1999 — № 66-P. 641−643.
- Kallapur S.G., Kramer B.W., Moss T.J. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. // Am. J. Physiol. 1995 — № 268 — P. 491 500.
- Kampschmidt R.F., Upchurch H.F., Eddington C.L., Pulliam L.A. Multiple biological activities of a partially purified leukocytic endogenous mediator. // Am. J. Physiol. 1973 -№ 224(3)-P. 530−3.
- Keeney S.E., Mathews M.J., Rassin D.K. Antioxydant enzyme responses to hyperox-ia in preterm and term rats after prenatal dexamethasone administration. // Pediatr. Res. -1993 -№ 33-P. 177−180.
- Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad spectrum antibiotics for spontaneous preterm labOR the ORACLE II randomized trial. // Lancet. 2001- № 357 — P. 991 996.
- Kevill K. A., Auten R. L., Schultz E. D. New bronchopulmonary dysplasia and long-term airway dysfunction. // Neonatal. R.espir. Dis. 2007- № 17 (2) — P. 1−8.
- Kolb M., Margetts P.J., Anthony D.C., et al. Transient expression of IL-1(3 induced acute lung injury and chronic repair leading to pulmonary fibrosis. // J. Clin. Invest. 2001 -№ 107-P. 1529−1536.
- Korte C., Styne D., Merritt T.A., Mayes D.M., Wertz A., Helbock H.J. Adrenocortical function in vety low birth weight infant: Improved testing sensivity and association with neonatal outcome. // J. Pediatr. 1996 — № 128 — P. 257−263.
- Kotecha S., Hodge R., Schraber J.A., et al. Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. // Pediatr. Res. 2004 — № 55 — P. 61−68.
- Kotecha S. Pathophysiology of chronic lung disease or prematurity. // Biol. Neonate. -2000-№ 78-P. 233−268.
- Kushnir M.M., Rockwood A.L., Roberts W.L., Pattison E.G., Owen W.E., Bunker A.M., Meikle A.W. Development and performance evaluation of a tandem mass spectrometry assay for 4 adrenal steroids. // Clin. Chem. 2006 — № 52(8) — P. 1559−67.
- Laborada G., Nesin M. Interleukin-6 and interleukin-8 are elevated in the cerebrospinal fluid of infants exposed to chorioamnionitis. // Biol. Neonate. 2005 — № 88(2) — P. 136−44.
- Lahra M.M., Jeffery H.E. A fetal response to chorioamnionitis is associated with early survival after preterm birth. // Am. J. Obstet. Gynecol. 2004 — № 190 — P. 147−151.
- Langstone C., Kida K., Reed M., et al. Human lung growth in late gestation and in the neonate. // Am. Rev. Respir. Dis. 1984 — № 129 — P. 607.
- Larsen C.G., Anderson A.O., Oppenheim J J., and Matsushima K. Production of in-terleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumor necrosis factor. // Immunology. 1989 — № 68 — P. 31−36.
- Laudy J.A.M. and Wladimiroff J.W. The fetal lung 1: developmental aspects. // Ultrasound Obstet. Gynecol. 2000 — № 16 — P. 284−290.
- Leonard E.J. NAP-1 (IL-8). // Immunology Today. 1990 — № 11 — P. 223−224.
- Lotze A., Mitchell B.R., Short B.L., et al. Multicenter Study of Surfactant (Beractant) Use in the Treatment of term Infants with severe respiratory failure. // J. Pediatr 1998 -№ 132 -P.40−7.
- Maniscalco W.M., Watkins R.H., Roper J.M., et al. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. // Pediatr Res. 2005 — № 58(3) — P.549−556.
- Markestad T., Fitzhardinge P.M. Growth and development in children recovering from bronchopulmonary dysplasia. // Journal of Pediatrics 1981 — Vol. 98 — P. 597 — 602.
- Marsh R.R., Handler S.D. Hearing impairment in ventilator-dependent infants and children. // Int J Pediatr Otorhinolaiyngol. 1990 — № 20 — P.213−217.
- Martich G.D., Danner R.L., Ceska M., and Suffredini A.F. Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: The effect of antiinflammatory agents. // J. Exp. Med. 1991 — № 173 — P. 1021−1024.
- Matsushima K. and Oppenheim J.J. Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. // Cytokine 1989 — № 1 — P. 2−13.
- May M., Strobel P., Seidenspinner S., et al. Apoptosis and proliferation in lung of stillborn fetuses and ventilated preterm infants with respiratory distress syndrome. // Eur Respir J. 2004 — № 23 — P. 113−121.
- Mayes L., Perkett E., Stahleman M.T. Severe bronchopulmonary dysplasia: a retrospective review // Acta Paediatrica. Scandinavica 1983 — Vol.72 — № 1−2. — P. 220−229
- McColley S.A. Bronchopulmonary dysplasia. Impact of surfactant replacement therapy. // Ped Clin North AM 1998 — № 45 — P.573−586.
- Meiseis S.J., Plunkett J.W., Roloff D.W., Pasick P.L., Stiefel G.S. Growth and development of preterm infants with respiratory distress syndrome and bronchopulmonary dysplasia. // Pediatrics. 1986 — № 77 — P.345−352.
- Merz U., Pfaffle R., Peschgens T., Hornchen H. The hypothalamic-pituitary-adrenal axis in preterm infants weighing < or = 1250 g: association with perinatal data and chronic lung disease. // Acta Paediatr. 1998 — № 87(3) — P.313−7.
- Miller RW, Woo P, Kellman RK et al. Tracheobronchial abnormalities in infants with bronchopulmonary dysplasia J Pediatr 1987- 111:779−782
- Mortesson W, Andreasson B, Lindroth M, et al. Potential of earlychest roentgen cx~amination in ventilator treated newborn infants to predict future lung function and disease. Pediatr Radiol 1989- 20:41
- Moya MP, Bisset GS 3rd, Auten RL Jr, Miller C, Hollingworth C, Frush DP. Reliability of CXR for the diagnosis of bronchopulmonary dysplasia. Pediatr Radiol. 2001 May-31(5):339−42.
- Nagaraj HS, Shott R, Fellows R, Yacoub U. Recurrent lobar atelectasis due to acquired bronchial stenosis in neonates. J Pediatr Surg 1980−15: 411—415
- Ng PC, Wong GW, Lam CW, Lee CH, Fok TF, Wong MY, Ma KC. Effect of multiple courses of antenatal corticosteroids on pituitary-adrenal function in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999- 80: F213-F216
- Northway W. H. Jr. Observations of bronchopulmonary dysplasia. J. Pediatr. 1979- 95: 819
- Northway WH, Rosan RC and Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967. 276: 357−368
- Oppenheim JJ, Neta R, Douches S. Interleukin 1 is a radioprotector. J Immunol. 1986 Apr l-136(7):2483−5.
- Palagina MV, Isachkova LM, Plekhova NG., Pathomorphology of rat lungs during postradiation period, Biuii Eksp Biol Med. 1997 Feb-123(2):233−7
- Pandit PB, Dunn MS, Kelly EN, et al. Surfactant replacement in neonates with early chronic lung disease. Pediatrics 1995- 95:851−854
- Parker CR Jr, Stankovic AK, Falany CN, Grizzle WE. Effect of TGF-beta on dehy-droepiandrosterone sulfotransferase in cultured human fetal adrenal cells. Ann N Y Acad Sei. 1995 Dec 29−774:326−8
- Parker CR Jr, Stankovic AK, Faye-Petersen O, Falany CN, Li H, Jian M. Effects of ACTH and cytokines on dehydroepiandrosterone sulfotransferase messenger RNA in human adrenal cells. Endoer Res. 1998 Aug-Nov-24(3−4):669−73.
- Perl AK, Whitsett JA. Molecular mechanisms controlling lung morphogenesis. Clin Genet 1999- 56:14
- Philip AG Chronic lung disease of prematurity: a short history. Semin Fetal Neonatal Med. 2009 Dec-14(6):333−8. Epub 2009 Aug 20.
- Ramanathan R. Optimal ventilatory strategies and surfactant to protect the preterm lungs. Neonatology. 2008−93(4):302−8
- Rebecca N. Baergen. Manual of Benirschke and Kaufmann’s. Pathology of the Human Placenta. Springfield, 2004
- Redline RW, Wilson-Costello D, Borawsky E, et al. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med 1998- 122: 1091- 1098
- Rennie J. M., Roberton N. R. S. A Manual of Neonatal Intensive Care. Oxford University Press, 2002. Ch. 12. Chronic lung disease. P. 204−214
- Roberts D, Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2006 Jul 19−3:CD004454
- Rojas MA, Gonzalez A, Bankalari E, Claure N, Poole C and Silva-Neto G (1995): Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr 126: 605−610
- Romero R, Espinoza J, Chaiworapongsa T, Kalache K. Infections and prematurity and the role of preventive strategies. Semin Neonatol 2002- 7:259−274
- Romero R., Espinoza J., Goncalves L.F. et al. // Semin. Reprod. Med. 2007. V. 25. P. 21−39
- Rozycki HJ, Comber PG, Huff TF. Cytokines and oxygen radicals after hyperoxya in preterm and term alveolar macrophages. Am J Physiol Lung Cell Mol Physiol 2002- 282 (6):L1222-L1228
- Rudolph AM, Roman C & Gournay V. Perinatal myocardial DNA and protein changes in the lamb: effect of Cortisol in the fetus. Pediatr Res 1999- 46: 141−146
- Saji F, Samejima Y, Kamiura S, Sawai K, Shimoya K, Kimura T. Cytokine production in chorioamnionitis. J Reprod Immunol. 2000 Jul-47(2): 185−96
- Saugstad OD. Bronchopulmonary dysplasia: oxidative stress and oxidants. Semin Neonatol 2003- 8:29−38
- Schmidt B, Cao L, Mackensen-Haen S, et al. Chorioamnionitis and inflammation of the feral lung. Am J Obstet Gynecol 2001- 185(1): 173- 177
- Schrod L., Neuhaus T., Horwitz A. E. et al. The effect of dexamethazone on respirator-dependent very-low-birthweight infants is best predicted by chest X-ray. // Pediatric Radiology. 2001−31:332−338
- Schroeder S.A., Shanon D.C., Mark E.J. Cellular interstitial pneumonitis in infants. A clinicopathologic study. Chest 1992- 101 (4): 1065−1069
- Scott SM, Watterberg KL. Effect of gestation age, postnatal age, and illness on plasma Cortisol concentrations in premature infants. J Clin Endocrin & metabolism. 1994- 78:266−270
- Sekar K., Duke J. Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia. Pediatr. Pulmonol., 1991- 10: 112−116
- Shah PS. Current perpectives on the prevention and management of chronic lung disease in preterm infants. Pediatr Drugs 2003- 5:463−480
- Shennan AT, Dunn MS, Ohlsson, Lennon K and Hoskins EM (1988): Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1982: 527−532
- Sherman JM, Lowitt S, Stephenson C, Ironson G. Factors influencing acquired subglottic stenosis in infants. J Pediatr 1986−109:322−327
- Short E.J., Kirchner H. L., Asaad G. R. et al. Developmental sequlae in preterm infants having a diagnosis of bronchopulmonary dysplasia. Arch. Pediatr. Adolesc. Med. 2007- 161 (11): 1082−1087
- Smidt B, Cao L, Mackensen-Haen S, et al. Chorioamnionitis and inflammation of the fetal lung. Am J Obstet Gynecol 2001- 185 (1): 173−177
- Smith MR, Munger WE, Kung HF, Takacs L, Durum SK. Direct evidence for an intracellular role for tumor necrosis factor-alpha 1. Microinjection of tumor necrosis factor kills target cells. J Immunol. 1990 Jan 1- 144(1): 162−9.
- Smith W.B., J.R. Gamble, I. Clark-Lewis, and M.A. Vadas. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991. 72, 65−72
- Smyth J. A., Tabachnic E., Dunkan W. J. et al. Pulmonary function and bronchial hyperreactivity in long-term survivors of bronchopulmonary dysplasia. // Pediatrics. — 1981. — Vol. 68.-P. 336−340
- Soil RF and Morley CJ. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants (Cochrain Review). In: The Cochrane Library, Issue 4, 2003. John Wiley and Sons, Ltd., Chichester, UK
- Soil RF, Blanco F. natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001−144
- Soli RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants (Cochrane Review). The Cochrane Library 2002-l:Update Software, Oxford.
- Soil RF. Multiple versus single dose natural surfactant extract for severe neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2000- 141
- Soil RF. Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000- 511
- Speer CP, Inflammation and bronchopulmonary dysplasia. Semin Neonatol. 2003- 8:29−39
- Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonat Med. 2006- 11(5): 354−362
- Sticherling, M., E. Bornscheuer, J.-M. Schroder, and E. Christophers. Localization of neutrophil-activating peptide-l/interleukin-8 immunoreactivity in normal and psoriatic skin. J. Invest. Dermatol. 1991. 96, 26−30
- Stiskal JA, Dunn MS, Shannan AT, et al. Alpha-1-proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. Pediatrics 1998- 101:89
- Stocker J.T., L.P.Dehne. Aquired pulmonary disease in the pediatric age grouop. Pulmonary Pathology, edited by D. Dail and S. Hammer, New York: Springer Verlag, 1987
- Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002- 347: 240−247
- Thomas M., Greenough A., Johnson A. H. et al. Frequent wheeze at follow-up of very preterm infants which factors are predictive? Arch. Dis. Child. 2003- 87
- Thomas W, Speer CP. Management of infants with bronchopulmonary dysplasia in Germany. Early Hum Dev 2005−81:155−163
- Toce SS, Farell PM, Leavitt LA, et al. Clinical and radiographic scoring system for assessing bronchopulmonary dysplasia. Am J Dis Child 1984- 138:581
- Tortorolo L, Vento G, Matassa PG, Zecca E, Romagnoli C. Early changes of pulmonary mechanics to predict the severity of bronchopulmonary dysplasia in ventilated preterm infants. // J Matern Fetal Neonatal Med. 2002 Nov-12(5):332−7
- Tremblay LN, Slutsky AS. Pathogenesis of ventilator-induced lung injury: trials and tribulations. Am J Physiol Lung Cell Mol Physiol 2005- 288: L596-L598
- Tsuchida S, Engelberts D, Roth M, et al. Continuous positive airway pressure causes lung injury in a rat model of sepsis. Am J Physiol Lung Cell Mol Physiol 2005- 289(4):L554-L564
- Uhlig S, Ranieri M, Slutsky AS. Biotrauma hypothesis of ventilator-induced lung injury. Am J Respir Crit Care Med 2004- 169: 314−315
- Van Daal GJ, Bos JA, Eijking EP, et al. Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice // Am Rev Respir Dis -1992 145:859−863
- Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M.: Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb-138(2):198−204.
- Van Marter LJ, Dammann O, Allred EN, et al. Chorioamnionitis, mechanical ventilation and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002- 140:171−176
- Van Waarde WM, Brus F, Okken A, Kimpen JL. Ureaplasma urealyticum colonization, prematurity and bronchopulmonary dysplasia. Eur Respir J 1997- 10:886−890
- Viscardi RM, Muhumuza CK, Rodriguez A, Fairchild KD, Sun CC, Gross
- Vohr BR, Coll CG, Lobato D, Yunis KA, O’Dea C, OhW. Neurodevelopmental and medical status of low-birthweight survivors of bronchopulmonary dysplasia at 10 to 12 years of age. Dev Med Child Neurol 1991−33:690−697
- Vyas J & Kotecha S. Effects of antenatal and postnatal corticosteroids on the preterm lung. Arch Dis Child Fetal Neonatal Ed 1997- 77: F147-F150
- Waage A, Halstensen A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987 Feb 14-l (8529):355−7.
- Walmrath D, Gunther A, Ghofrani HA, et al, Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am J Respir Crit Care Med 154:57−62, 1996
- Wang JY, Yeh TF, Lin YC, Miyamura K, Holmskov U & Reid KB. Measurment of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome. Thorax. 1996- 51:907−913
- Watteberg KL, Scott SM, Backstorm C, et al. Links between early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent ductus arteriosus. Pediatrics 2000- 105−320
- Watterberg KL & Scott SM. Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia. Pediatrcs 1995- 95:120−125
- Watterberg KL, Demers LM, Scott SM, Murphy S. Chorionamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996- 97:210−215
- Watterberg KL, Gerdes JS, Cook KL. Impaired glucocorticoid synthesis in premature infants developing chronic lung disease. Pediatr Res 2001- 50: 190−195
- Watterberg KL, Scott SM, Backstrom C, Gifford KL & Cook KL. Links between Early adrenal function and respiratory outcome in preterm infants: airway inflammation and patent dustus arteriosus. Pediatrics 2000- 105: 320−324
- Watterberg KL, Scott SM, Naeye RL Chorioamnionitis, Cortisol, and acute lung disease in very low birth weight infants. Pediatrics. 1997 Feb-99(2):E6.
- Watterbere KL. Demers LM. Scott SM. Murnhv S. Chorioamnionitis and early lungt^j J ¦> — i. J J Oinflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics. 1996 Feb-97(2):210−5
- Watts DH, Krohn MA, Hillier SL, Eschenbach DA. The association of occult amniotic fluid infection with gestation age and neonatal outcome among women in preterm labor. Obstet Gynecol 1992- 79:351−357
- Weingerger B, Laskin DL, Heck DE, et al. Oxygen toxicity in premature infants. Toxicol Appl Pharmacol 2002- 181:60
- Weinstein MR, Peters ME, Sadek M, Palta M. A new radiographic scoring system for bronchopulmonary dysplasia. Newborn Lung Project. Pediatr Pulmonol. 1994 Nov-18(5):284−9
- Wenstrom KD, Andrews WW, Hauth JC, et al. Elevated second trimester amniotic fluid Interleukin 6 levels predict preterm delivery. Am J Obstet Gynecol 1998- 178:546 550
- Wilson MG, Mikity VG. A new form of respiratory disease in premature infants. J Gis Child 1960−99:489−499
- Wong P. M., Lees A. N., Louw J. et al. Emphisema in young adult survivous of moderate-to-severe bronchopulmonary dysplasia. // Eur. Respir. J. 2008- 32: 321−328
- Yoder BA, Coalson JJ, Winter VT, et al. Effects of neonatal colonization with Ureaplasma urealyticum on pulmonary disease in the immature baboon. Pediatr Res 2003- 54:797−807
- Yost CC, Soll RF. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome (Cochrane Review). The Cochrane Library 2002-l:Update Software, Oxford
- Z. / J. 1U v.l.11., Wlglli i, iin u.U., uaj liiy u., naiuui y j. vjiuvv 111 anu vav v viwpint-in. vjivery low birthweight infants recovering from bronchopulmonary dysplasia. Archives of Disease in Childhood, 1983, 58, 791 — 794
- Zaretsky MV, Alexander JM, Byrd W, Bawdon RE. Transfer of inflammatory cytokines across the placenta. Obstet Gynecol. 2004 Mar-103(3):546−50.